Is Pfizer-Allergan Deal The AOL-Time Warner Of Our Time?

The Monday agreement by Pfizer (NYSE:PFE) to “buy” Allergan (NYSE:AGN) for $160 billion, including 11.3 shares in the new company stock, plus cash, may represent a similar peak in the health care sector.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.